Affinity Asset Advisors
New York City, New Yorkaffinityadv.com
Overview
Affinity Asset Advisors is a hedge fund manager founded in 2017 that pursues a long-short equity strategy focused on the healthcare sector, particularly pharmaceutical and biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Jasper Therapeutics | Aug 2026 | PIPE | Lead |
| Climb Bio, Inc. | May 2026 | Private Placement | Co-investor |
| TRexBio | Jan 2026 | Series B Extension | Lead |
| Odyssey Therapeutics | Sep 2025 | Series D | Co-investor |
| LEXEO Therapeutics | May 2025 | Private Placement | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?